Patents by Inventor Peyman Bjorklund

Peyman Bjorklund has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for assessing and treating adrenal diseases and disorders
    Patent number: 9982026
    Abstract: The present invention relates to the discovery that mutations in KCNJ5 are associated with adrenal diseases and disorders. The invention includes compositions and methods for the assessment, characterization and treatment of adrenal diseases and disorders, based upon the presence or absence of a KCNJ5 mutation that is associated with an adrenal disease or disorder.
    Type: Grant
    Filed: January 4, 2012
    Date of Patent: May 29, 2018
    Assignee: YALE UNIVERSITY
    Inventors: Richard P. Lifton, Bixiao Zhao, Murim Choi, Goran Akerstrom, Gunnar Westin, Peyman Bjorklund, Per Hellman
  • Compositions and Methods for Assessing and Treating Adrenal Diseases and Disorders
    Publication number: 20140127126
    Abstract: The present invention relates to the discovery that mutations in KCNJ5 are associated with adrenal diseases and disorders. The invention includes compositions and methods for the assessment, characterization and treatment of adrenal diseases and disorders, based upon the presence or absence of a KCNJ5 mutation that is associated with an adrenal disease or disorder.
    Type: Application
    Filed: January 4, 2012
    Publication date: May 8, 2014
    Applicant: Yale University
    Inventors: Richard P. Lifton, Bixiao Zhao, Murim Choi, Goran Akerstrom, Gunnar Westin, Peyman Bjorklund, Per Hellman
  • Mutant Lrp5/6 Wnt-Signaling Receptors in Cancer Diagnosis, Prognosis, and Treatment
    Publication number: 20080227734
    Abstract: A novel mutant form of lrp5 and lrp6 genes, the mutant LRP5 and LRP6 receptor proteins expressed therefrom, and a cell line which expresses the mutant LRP5 and/or LRP6 receptor proteins. Methods of diagnosing, prognosing and treating LRP5 related diseases, specifically hyperthyroidism and parathyroid tumors, and kits suitable for rapid on-site testing. Finally, methods of screening for agents capable of modulating the mutant LRP5 or LRP6 receptor proteins and pharmaceutical compositions comprising the selected agents.
    Type: Application
    Filed: November 24, 2004
    Publication date: September 18, 2008
    Inventors: Gunnar Westin, Peyman Bjorklund, Goran Akerstrom